Table 6.
Clinical data distributions of MACH14 sample (N = 2,860)
| Characteristics | Sample frequency | N (%) with available dataa |
|---|---|---|
| Lowest ever absolute CD4 count (cells/mm3), mean (SD) | 213 (212.9) | 1,207 (42.2) |
| Duration of known HIV status at time of enrollment (month), mean (SD) | 15.9 (31) | 2,118 (74.1) |
| Highest viral load in record (log10 copies/ml), mean (SD) | 4.05 (0.7) | 2,370 (82.9) |
| CDC stage at time of entry into study, n (%) | 2,059 (72.0) | |
| A | 174 (8.5) | |
| B | 114 (5.5) | |
| C | 320 (15.5) | |
| Unknown | 1,451 (70.5) | |
| Currently use or ever used any kind of alternative or complementary medications, treatments, or supplements, n (%) | 2,274 (79.5) | |
| No | 687 (30.2) | |
| Yes | 739 (32.5) | |
| Unknown | 848 (37.3) | |
| Ever had an HIV-related infection or malignancy or complication, n (%) | 2,274 (79.5) | |
| No | 601 (26.4) | |
| Yes | 804 (35.4) | |
| Unknown | 869 (38.2) | |
| Ever taken or currently on PCP prophylaxis, n (%) | 2,232 (78.0) | |
| No | 281 (12.6) | |
| Yes, at enrollment | 159 (7.1) | |
| Yes, only for a time before enrollment | 12 (0.5) | |
| Yes, only at a time starting after enrollment | 62 (2.8) | |
| Yes, for a time prior to enrollment and after enrollment | 57 (2.6) | |
| Yes during the study, but unknown if prior to study | 142 (6.4) | |
| Known | 1,519 (68.1) | |
| Ever taken or currently on TB prophylaxis, n (%) | 2,017 (70.5) | |
| No | 156 (7.7) | |
| Yes, at enrollment | 27 (1.3) | |
| Yes, only for a time before enrollment | 22 (1.1) | |
| Yes, only at a time starting after enrollment | 32 (1.6) | |
| Yes, for a time prior to enrollment and after enrollment | 15 (0.7) | |
| Yes during the study, but unknown if prior to study | 7 (0.3) | |
| Unknown | 1,758 (87.2) |
a
N refers to the number of people with valid values, and the percentage is the percentage of the total sample (N = 2,860)